The suspected sources of free radicals in dystrophin deficiency include damaged mitochondria, the activity of nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs) and xanthine oxidase (XO), expressed either in inflammatory cells or in muscle fibers, and the decoupling of neuronal nitric oxide synthase (nNOS) from the sarcolemma [79,80,81,82] (Figure 3); therefore, drugs acting at these levels have been tested in the treatment of DMD. Here, NOS1 is linked to Duchenne muscular dystrophy.